高级搜索
骨巨细胞瘤的体外药物敏感试验[J]. 肿瘤防治研究, 1998, 25(2): 86-88.
引用本文: 骨巨细胞瘤的体外药物敏感试验[J]. 肿瘤防治研究, 1998, 25(2): 86-88.
In Vitro Chemosensitivity Experiment of Giant Cell Tumor of Bone[J]. Cancer Research on Prevention and Treatment, 1998, 25(2): 86-88.
Citation: In Vitro Chemosensitivity Experiment of Giant Cell Tumor of Bone[J]. Cancer Research on Prevention and Treatment, 1998, 25(2): 86-88.

骨巨细胞瘤的体外药物敏感试验

In Vitro Chemosensitivity Experiment of Giant Cell Tumor of Bone

  • 摘要: 骨巨细胞瘤是一种半恶性的肿瘤,术后复发率较高。作者取经病理证实的骨巨细胞瘤标本(共7例)进行体外培养,并用MTT法进行原代细胞的化疗药物敏感试验及梯度浓度的化疗药物的敏感试验,结果显示,在常规剂量下(临床一次用量的1/250)骨巨细胞瘤对阿霉素及顺氨氯铂中度敏感,梯度试验表明,阿霉素、顺氨氯铂及甲氨蝶吟的最低有效抑制浓度分别为0.4ug/ml、2ug/ml和3us/ml,因此,骨巨细胞瘤可以应用阿霉素、顺氨氯铂等进行治疗以降低术后复发率,但由于有效浓度较高,不适合常规的静脉及局部给药,而仅适用于良好缓释载体与敏感化疗药物制成的缓释制剂的局部应用。

     

    Abstract: Giant cell tumor of bone (GCT)is a semi—malignant tumor.There are high recurrentrates in this tumor after operation.7 specimens of GCT proved by pathology were cultured,then the chemosensisitivity of the primary cultures were tested by using MTT method,The results showed there were middle degree sensitivity to GCT in usual dose (1/250 of one clinical dose )of cisplachitin (CDDP)and adriamycin (ADM),The results of chemosensitivity test of echelon dense of chemical drug showed the lowest effective dense of ADM,CDDP and MTX were 0.4ug/ml, 2ug/ml, 3ug/ml, It is concluded GCT may be treated by ADM and CDDP to reduce the recurrent rate of GCT after operation. As the effeective dense of the drug is high,usual injection in vein and local giving are not suited,and the local treatment by drug delivery system made out by good sustained release carrier and sensitivity chemical drug may be the only effective mothed.

     

/

返回文章
返回